Upregulation of myocardial estrogen receptors in human aortic stenosis

Circulation. 2004 Nov 16;110(20):3270-5. doi: 10.1161/01.CIR.0000147610.41984.E8. Epub 2004 Nov 8.

Abstract

Background: Estrogen receptor (ER)-mediated effects have been associated with the modulation of myocardial hypertrophy in animal models and in humans, but ER expression in the human heart and its relation to hypertrophy-mediated gene expression have not yet been analyzed. We therefore investigated sex- and disease-dependent alterations of myocardial ER expression in human aortic stenosis together with the expression of hypertrophy-related genes.

Methods and results: ER-alpha and -beta, calcineurin A-beta, and brain natriuretic peptide (BNP) mRNA were quantified by real-time polymerase chain reaction in left ventricular biopsies from patients with aortic valve stenosis (n=14) and control hearts with normal systolic function (n=17). ER protein was quantified by immunoblotting and visualized by immunofluorescence confocal microscopy. ER-alpha mRNA and protein were increased 2.6-fold (P=0.003) and 1.7-fold (P=0.026), respectively, in patients with aortic valve stenosis. Left ventricular ER-beta mRNA was increased 2.6-fold in patients with aortic valve stenosis (P<0.0001). ER-alpha and -beta were found in the cytoplasm and nuclei of human hearts. A strong inverse correlation exists between ER-beta and calcineurin A-beta mRNA in patients with aortic valve stenosis (r=-0.83, P=0.002) but not between ER-alpha or -beta and BNP mRNA.

Conclusions: ER-alpha and -beta in the human heart are upregulated by myocardial pressure load.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aortic Valve Stenosis / drug therapy
  • Aortic Valve Stenosis / genetics
  • Aortic Valve Stenosis / metabolism*
  • Calcineurin / biosynthesis
  • Calcineurin / genetics
  • Cell Nucleus / metabolism
  • Cytoplasm / metabolism
  • Diuretics / pharmacology
  • Diuretics / therapeutic use
  • Estrogen Receptor alpha / biosynthesis*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor beta / biosynthesis*
  • Estrogen Receptor beta / genetics
  • Female
  • Gene Expression Regulation
  • Heart Ventricles / metabolism
  • Hormone Replacement Therapy
  • Humans
  • Male
  • Microscopy, Fluorescence
  • Middle Aged
  • Natriuretic Peptide, Brain / biosynthesis
  • Natriuretic Peptide, Brain / genetics
  • Pressure
  • RNA, Messenger / biosynthesis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Up-Regulation / physiology*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • RNA, Messenger
  • Natriuretic Peptide, Brain
  • Calcineurin